These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29979555)

  • 1. [Advances in the research of inhibitors of enzymes of bacterial peptidoglycan biosynthesis].
    Liu F; Meng HY; Sun ZY; Li DY; Jin YY; Yang ZY; Wu SJ; Chen J
    Yao Xue Xue Bao; 2017 Mar; 52(3):362-70. PubMed ID: 29979555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F.
    Hrast M; Sosič I; Sink R; Gobec S
    Bioorg Chem; 2014 Aug; 55():2-15. PubMed ID: 24755374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.
    Kotnik M; Anderluh PS; Prezelj A
    Curr Pharm Des; 2007; 13(22):2283-309. PubMed ID: 17692001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery.
    Kumar D; Sarkar N; Roy KK; Bisht D; Kumar D; Mandal B; Rajagopal M; Dey YN
    Curr Drug Targets; 2023; 24(8):627-647. PubMed ID: 37291783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
    Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
    Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
    Silver LL
    Biochem Pharmacol; 2006 Mar; 71(7):996-1005. PubMed ID: 16290173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.
    Hrast M; Turk S; Sosič I; Knez D; Randall CP; Barreteau H; Contreras-Martel C; Dessen A; O'Neill AJ; Mengin-Lecreulx D; Blanot D; Gobec S
    Eur J Med Chem; 2013 Aug; 66():32-45. PubMed ID: 23786712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidoglycan biosynthesis machinery: a rich source of drug targets.
    Gautam A; Vyas R; Tewari R
    Crit Rev Biotechnol; 2011 Dec; 31(4):295-336. PubMed ID: 21091161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.
    Hering J; Dunevall E; Ek M; Brändén G
    Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the forgotten transglycosylases.
    Halliday J; McKeveney D; Muldoon C; Rajaratnam P; Meutermans W
    Biochem Pharmacol; 2006 Mar; 71(7):957-67. PubMed ID: 16298347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to antibiotics targeted to the bacterial cell wall.
    Nikolaidis I; Favini-Stabile S; Dessen A
    Protein Sci; 2014 Mar; 23(3):243-59. PubMed ID: 24375653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the Mur enzymes: development of novel inhibitors.
    El Zoeiby A; Sanschagrin F; Levesque RC
    Mol Microbiol; 2003 Jan; 47(1):1-12. PubMed ID: 12492849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection.
    Sapkota M; Marreddy RKR; Wu X; Kumar M; Hurdle JG
    Anaerobe; 2020 Feb; 61():102129. PubMed ID: 31760080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bacterial cell wall as a source of antibacterial targets.
    Green DW
    Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of Mur ligases as an antibacterial target.
    Kouidmi I; Levesque RC; Paradis-Bleau C
    Mol Microbiol; 2014 Oct; 94(2):242-53. PubMed ID: 25130693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis.
    Bratkovic T; Lunder M; Urleb U; Strukelj B
    J Basic Microbiol; 2008 Jun; 48(3):202-6. PubMed ID: 18506905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.
    Hervin V; Roy V; Agrofoglio LA
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
    Campbell JW; Cronan JE
    Annu Rev Microbiol; 2001; 55():305-32. PubMed ID: 11544358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.